Company Filing History:
Years Active: 2001-2008
Title: Innovations by John Ross, Jr. in Cardiac Gene Therapy
Introduction
John Ross, Jr. is a notable inventor based in La Jolla, California, recognized for his contributions to cardiac gene therapy. He holds four patents that focus on innovative methods to improve cardiac function and treat heart failure. His work has significant implications for the treatment of heart diseases, particularly in enhancing the quality of life for patients.
Latest Patents
One of his latest patents is centered on methods for cardiac gene transfer. This patent describes techniques for delivering genes to improve cardiac function, utilizing viral vectors, isolation of the heart from systemic circulation, and the induction of hypothermia or cardiac arrest. The method has shown promising results, leading to high-level, long-term expression of reporter genes and enhanced cardiac function in hamster models of heart disease. Another significant patent addresses the treatment of heart failure following myocardial infarction. This method involves administering an angiotensin II inhibitor for 8-12 weeks, followed by a growth hormone for 1-3 weeks, providing a novel approach to managing heart failure.
Career Highlights
Throughout his career, John Ross, Jr. has worked with esteemed institutions such as the University of California and Corazon Technologies, Inc. His research and innovations have contributed to advancements in cardiac health and gene therapy.
Collaborations
John has collaborated with notable individuals in the field, including Kenneth R. Chien and Brent Richard Constantz. These collaborations have further enriched his research and development efforts.
Conclusion
John Ross, Jr. is a pioneering inventor whose work in cardiac gene therapy has the potential to transform the treatment of heart diseases. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.